Suppressive effects of furonaphthoquinone NFD-37 on the production of lipopolysaccharide-inducible inflammatory mediators in macrophages RAW 264.7

被引:0
作者
Kim Min-Hee
Shin Hyun-Mo
Lee Yong Rok
Chung Eun Yong
Chang Yoon Sook
Min Kyung Rak
Kim Youngsoo
机构
[1] Chungbuk National University,College of Pharmacy & Research Center for bioresource and Health
[2] Yeungnam University,School of Chemical Engineering and Technology
来源
Archives of Pharmacal Research | 2005年 / 28卷
关键词
Furonaphthoquinone; NO; PGE; Cytokine; Anti-inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
2-Methyl-2-(2-methylpropenyl)-2,3-dihydronaphthoquinone[2,3-b]furan-4,9-dione (NFD-37) is a synthetic furonaphthoquinone compound. In this study, we determined that NFD-37 could inhibit the lipopolysaccharide (LPS)-induced production of inflammatory mediators in macrophages RAW 264.7. This compound inhibited LPS-induced nitric oxide (NO) or prostaglandin (PG) E2 production in dose-dependent manners, with IC50 values of 7.2 μM and 5.3 μM, respectively. As the positive controls, pyrrolidine dithiocarbamate (30 μM) exhibited a 57% inhibition of NO production, and NS-398 (1 μM) manifested a 48% inhibition of PGE2 production. The inhibitory effects of NFD-37 on NO and PGE2 production were determined to occur in conjunction with the suppression of inducible NO synthase or cyclooxygenase-2 expression. NFD-37 also inhibited the production of LPS-inducible tumor necrosis factor-α, interleukin (IL)-1β and IL-6, at IC50 values of 4.8–8.9 μM. We also determined the anti-inflammatory efficacy of NFD-37 using carrageenin-induced paw edema in experimental mice.
引用
收藏
页码:1170 / 1176
页数:6
相关论文
共 86 条
  • [1] Arakawa T.(1998)Prostaglandins in the stomach: an update J. Clin. Gastroenterol. 27 S1-S11
  • [2] Higuchi K.(2004)Current approaches to prevent NSAID-induced gastropathy: COX selectivity and beyond Br. J. Clin. Phamacol. 58 587-600
  • [3] Fukuda T.(2003)Pharmacology and clinical action of COX-2 selective NSAIDs Adv. Exp. Med. Biol. 523 201-214
  • [4] Fujiwara Y.(2002)Anti-inflammatory agents and renal function Semin. Arthritis Rheum. 32 33-42
  • [5] Kobayashi K.(1994)Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids J. Clin. Invest. 93 1095-1101
  • [6] Kuroki T.(2001)LPS induction of gene expression in human monocytes Cell Signal. 13 85-94
  • [7] Becker J. C.(2003)The pathophysiological role of cytokines Leg. Med. 5 S45-S57
  • [8] Domschke W.(2002)Nitric oxide as a unique signaling molecule in the vascular system: a historical overview J. Physiol. Pharmacol. 53 503-514
  • [9] Pohle T.(1997)Transcriptional regulation of human prostaglandin endoperoxide synthase-2 gene in vascular endothelial cells Adv. Exp. Med. Biol. 407 139-144
  • [10] Bovill J. G.(2005)Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipoteichoic acid and related cell wall antigens from J. Med. Microbiol. 54 315-321